Collin J Weber
Medical Practice in Atlanta, GA
License number
New Jersey 25MA05610000
Issued Date
Mar 25, 1991
Expiration Date
Jun 30, 1993
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Atlanta, GA
Personal information
See more information about Collin J Weber at radaris.comName
Address
Phone
3028 Vinings Forest Way SE, Atlanta, GA 30339
3028 Vinings Way, Atlanta, GA 30339
Organization information
See more information about Collin J Weber at bizstanding.comEmory Clinic - Collin J Weber MD
1365 Clifton Rd NE, Atlanta, GA 30322
Categories:
General Surgeons
Phone:
(404) 778-3322 (Phone)
Professional information
See more information about Collin J Weber at trustoria.com
Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)
Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery
Address:
Emory Clinic General/Vsclr Sgry
1365 Clifton Rd NE, Atlanta 30322
(404) 778-4000 (Phone)
1365 Clifton Rd NE, Atlanta 30322
(404) 778-4000 (Phone)
Certifications:
Critical Care Surgery, 1990, General Surgery, 1999
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Emory Clinic General/Vsclr Sgry
1365 Clifton Rd NE, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
1365 Clifton Rd NE, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1971
Columbia Presby Med Center
Graduated: 1972
Columbia University College Of Physicians and Surgeons
Graduated: 1971
Columbia Presby Med Center
Graduated: 1972
Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)
Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
EMORY CLINIC - SURGERY
1365 Clifton Rd NE SUITE A3333, Atlanta 30322
(404) 778-5451 (Phone), (404) 778-3101 (Fax)
1365 Clifton Rd NE SUITE A3333, Atlanta 30322
(404) 778-5451 (Phone), (404) 778-3101 (Fax)
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Columbia University / College of Physicians And Surgeons
Collin Weber, Atlanta GA
Collin Weber, Atlanta GA
Work:
The Emory Clin
1365 Clifton Rd Ne, Atlanta, GA 30322 The Emory Clin
The Emory Clinic BUILDING A, Atlanta, GA 30322
1365 Clifton Rd Ne, Atlanta, GA 30322 The Emory Clin
The Emory Clinic BUILDING A, Atlanta, GA 30322
Method Of Inhibiting Immune System Destruction Of Transplanted Viable Cells
Method Of Inhibiting Immune System Destruction Of Transplanted Viable Cells
US Patent:
7041634, May 9, 2006
Filed:
Mar 27, 1998
Appl. No.:
09/049865
Inventors:
Collin J. Weber - Atlanta GA, US
Mary K. Hagler - Loganville GA, US
Peter S. Linsley - Seattle WA, US
Judith A. Kapp - Atlanta GA, US
Susan A. Safley - Decatur GA, US
Mary K. Hagler - Loganville GA, US
Peter S. Linsley - Seattle WA, US
Judith A. Kapp - Atlanta GA, US
Susan A. Safley - Decatur GA, US
Assignee:
Emory University - Atlanta GA
Bristol Myers-Squibb Company - New York NY
Bristol Myers-Squibb Company - New York NY
International Classification:
A61K 38/00
US Classification:
514 2, 4241561, 4241371, 4241411, 424 937, 424812, 530350
Abstract:
This invention provides a method of inhibiting viable cells transplanted into a subject from being destroyed by the subject's immune system which comprises: a) containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; and b) treating the subject with a substance which inhibits an immune-system costimulation event in an amount effective to inhibit the subject's immune system from responding to said contained cells or tissue. In one embodiment, the substance which inhibits an immune-system costimulation event is CTLA4. Also provided by this invention is a method of treating diabetes in a subject which comprises: a) containing viable insulin-producing cells, or tissue comprising such cells, within a device comprising a semipermeable membrane; b) transplanting an effective amount of such contained viable insulin-producing cells into the subject; and c) treating the subject with an effective amount of a substance which inhibits an immune-system costimulation event.
Method Of Containing Core Material In Microcapsules
Method Of Containing Core Material In Microcapsules
US Patent:
5795570, Aug 18, 1998
Filed:
Apr 7, 1995
Appl. No.:
8/418953
Inventors:
Collin J. Weber - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3512, C12N 1110, B01J 1320
US Classification:
424 937
Abstract:
A core material such as animal tissue or cells is contained within a semipermeable vessel which may be a microcapsule, hollow fiber or plastic membrane having a semipermeable wall by a method that prevents the core material from incorporation into the wall of the vessel. This is accomplished by suspending the core material in a solution of polysaccharide gum such as an alkali metal alginate in an amount between about 0. 2% and about 0. 5%, removing and washing the core material to remove all but a thin layer of polysaccharide gum, and gelling the polysaccharide gum with multivalent cations or other means to form a pretreated core material. The pretreated core material is contained within a semipermeable vessel such as by suspending the pretreated core material in a solution of alkali metal alginate, forming the suspension into droplets, gelling the droplets to form temporary shape-retaining capsules and treating the capsules with a polymeric material having groups that react with and crosslink acid groups of the capsules to form a permanent semipermeable membrane around the capsules. A second permanent semipermeable membrane may be formed around the capsules to form double-walled microcapsules by further treating the capsules with the polymeric material. The semipermeable vessel may be impermeable to immune factors.